Physician profile
Lawrence E Yellen
NPI 1386737195
$2,150.09
in general payments reported to CMS, 2019-2025
14 companies · $406 in 2025
The $406 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $351 · 2020: $91.17 · 2021: $344 · 2022: $392 · 2023: $417 · 2024: $148 · 2025: $406.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $855 · Education: $117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $854.94 |
| Education | $117.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $526.30 | 2019-2025 | Olumiant, Taltz, Ebglyss |
| Janssen Biotech, INC. | $266.42 | 2019-2025 | Tremfya |
| Abbvie INC. | $244.33 | 2019-2025 | Skyrizi |
| Novartis Pharmaceuticals Corporation | $227.72 | 2019-2023 | |
| Incyte Corporation | $183.04 | 2022-2023 | Opzelura |
| Leo Pharma INC. | $171.19 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $154.21 | 2023 | Sotyktu |
| Regeneron Healthcare Solutions, INC. | $115.25 | 2019-2022 | |
| Abbott Laboratories | $60.90 | 2021 | |
| Amgen INC. | $50.58 | 2019-2022 | |
| Abiomed | $48.03 | 2019-2021 | |
| Pfizer INC. | $46.14 | 2022-2023 | |
| Ucb, INC. | $28.92 | 2019 | |
| Dermavant Sciences, INC. | $27.06 | 2023 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Yellen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.